Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2012, Article ID 397267, 8 pages
Review Article

Immunotherapy of Genitourinary Malignancies

Department of Urology, Osaka Medical College, Takatsuki, Osaka 569-8686, Japan

Received 8 October 2011; Accepted 26 December 2011

Academic Editor: M. Roach

Copyright © 2012 Teruo Inamoto and Haruhito Azuma. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [8 citations]

The following is the list of published articles that have cited the current article.

  • Conghui Han, Lin Hao, Meng Chen, Jianpeng Hu, Zhenduo Shi, Zhiguo Zhang, Bingzheng Dong, Yu Fu, Changsong Pei, and Yongping Wu, “Target expression of Staphylococcus enterotoxin A from an oncolytic adenovirus suppresses mouse bladder tumor growth and recruits CD3+ T cell,” Tumor Biology, 2013. View at Publisher · View at Google Scholar
  • Alexandra Drakaki, and David F. McDermott, “Novel Immunotherapies in GU Malignancies,” Current Oncology Reports, vol. 15, no. 3, pp. 224–231, 2013. View at Publisher · View at Google Scholar
  • Drew Freilich, Eric Moskowitz, Nicholas Feuer, Muhammad Choudhury, John Phillips, and Sensuke Konno, “Possible Chemosensitizing and Potent Anticancer Effects of D-Fraction in Combination with Vitamin C on Three Prevalent Urologic Cancer Cells,” Journal of Cancer Therapy, vol. 05, no. 14, pp. 1402–1411, 2014. View at Publisher · View at Google Scholar
  • Dan Ishihara, Puneeth Iyengar, Jeffrey Meyer, Robert Timmerman, Hak Choy, and Raquibul Hannan, “The combination of radiation therapy and immunotherapy for genitourinary cancer treatment: rationale, current evidence, and prospects,” Journal of Radiation Oncology, 2015. View at Publisher · View at Google Scholar
  • Fouad Aoun, Hampig R Kourie, Spyridon Sideris, Thierry Roumeguère, Roland van Velthoven, and Thierry Gil, “Checkpoint inhibitors in bladder and renal cancers: results and perspectives,” Immunotherapy, 2015. View at Publisher · View at Google Scholar
  • Ali Panah, and Chandran Tanabalanpp. 209–221, 2015. View at Publisher · View at Google Scholar
  • Said Abdallah Al-Mamari, and Salim Said Al-Busaidy, “Treatment,” Urological Cancer Management, pp. 81–98, 2015. View at Publisher · View at Google Scholar
  • Roy Rampling, Willie Stewart, Sarah Kutscher, Norbert Hilf, Lesley McGuigan, Oliver Schoor, Sharon Peoples, Paul J. Mulholland, Omar Al-Salihi, Alan Jackson, Juha Lindner, Jane Peters, Karen Hill, Harpreet Singh-Jasuja, Sarah E. Halford, James W.A. Ritchie, Allan James, Christopher J. Twelves, Catherine McBain, and Sarah Jefferies, “A cancer research UK first time in human phase i trial of IMA950 (novel multipeptide therapeutic vaccine) in patients with newly diagnosed glioblastoma,” Clinical Cancer Research, vol. 22, no. 19, pp. 4776–4785, 2016. View at Publisher · View at Google Scholar